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ABSTRACT
Bacterial artificial chromosomes (BACs) derived
from genomes of large DNA viruses are powerful
tools for functional delineation of viral genes.
Current methods for cloning the genomes of large
DNA viruses as BACs require prior knowledge of the
viral sequences or the cloning of viral DNA frag-
ments, and are tedious because of the laborious
process of multiple plaque purifications, which is
not feasible for some fastidious viruses. Here, we
describe a novel method for cloning the genomes
of large DNA viruses as BACs, which entails direct
in vitro transposition of viral genomes with a BAC
cassette, and subsequent recovery in Escherichia
coli. Determination of insertion sites and adjacent
viral sequences identify the BAC clones for genetic
manipulation and functional characterization.
Compared to existing methods, this new approach
is highly efficient, and does not require any infor-
mation on viral sequences or cloning of viral DNA
fragments, and plaque purifications. This method
could potentially be used for discovering previously
unidentified viruses.
INTRODUCTION
Large DNA viruses, including herpesviruses, poxviruses,
baculoviruses, nudiviruses and ascoviruses, contain large
linear or circular double-stranded DNA genomes with
sizes over 80 kbp. These viruses aﬀect vertebrates (mam-
mals, birds, reptiles, amphibians and ﬁshes) and inverte-
brates (insects and mollusks) across the animal kingdom.
Genetic mutations of viral genomes are a standard
approach for functional delineation of viral genes. The
cloning of genomes of large DNA viruses as bacterial arti-
ﬁcial chromosomes (BACs) in Escherichia coli could
greatly facilitate their genetic manipulation (1). The gen-
omes of several large DNA viruses, including human
cytomegalovirus, herpes simplex virus type 1, Epstein-
Barr virus, Kaposi’s sarcoma-associated herpesviruses
(KSHV), murine cytomegalovirus, pseudorabies virus,
Marek’s disease virus, murine gammaherpesvirus-68
(MHV-68), rhesus rhadinovirus, varicella-zoster virus,
guinea pig cytomegalovirus and vaccinia virus have been
cloned as BACs in the last decade (1–14). These recombi-
nant BACs have become important tools for studying the
functions of viral genes of these viruses (15,16).
Currently, the cloning of the genome of a large DNA
virus as a BAC is achieved by homologous recombination
between the viral genome and a BAC cassette with ﬂank-
ing viral DNA fragments, or alternatively, as overlapping
cosmid inserts encompassing the entire viral genome, with
one insert containing the BAC vector (15). These methods
require some prior knowledge of the viral sequence or the
cloning of a viral DNA fragment to generate the BAC
cassette or the BAC vector-containing cosmid insert.
The process of multiple plaque puriﬁcations is tedious
and time-consuming even under drug selection, and is
further aggravated by the low recombination eﬃciency
in cells and the slow growth nature of some large DNA
viruses. For fastidious viruses, such as KSHV that do not
produce any plaques in culture, this becomes a daunting
task (12). In this study, we have developed a novel method
for direct eﬃcient cloning of genomes of large
DNA viruses as BACs without any prior knowledge of
viral sequences or cloning of viral fragments. We have
used MHV-68, a gammaherpesvirus with a 110kbp
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the high eﬃciency, simplicity and rapidness of this
method.
MATERIALS AND METHODS
Celland virus
Both NIH3T12 cells and MHV-68 WUMS strain (ATCC
VR1465) were kindly provided by Dr Herbert W. Virgin
IV at Washington University School of Medicine.
NIH3T12 cells were grown in Dulbecco’s modiﬁed
Eagle’s medium (DMEM) supplemented with 10% fetal
calf serum and 50mg/ml of gentamycin. The growth of
MHV-68 in NIH 3T12 cells and virus plaque assay were
carried out as previously described (17).
Isolationof viral and BACDNA
Extraction of viral DNA from virions was carried out as
previously described with minor modiﬁcations (17).
Infected cells were subjected to three cycles of freeze-
thaw, and cell debris was removed by low-speed centrifu-
gation at 5000 r.p.m. for 15min. Cleared supernatant was
spun at 10000g for 2h to pellet the virus. The virus pellet
was then resuspended in DNase buﬀer containing 50mM
Tris–HCl at pH 7.5, 10mM MgCl2 and 50mg/ml of BSA.
DNase was added and the virus suspension was incubated
for 1h at 378C to allow digestion of cellular DNA. After
centrifugation at 111000g for 1h with a 20% sucrose
cushion, the cellular DNA-free virus in the pellet was
resuspended and treated with proteinase K in a lysis
buﬀer containing 20mM Tris–HCl at pH 7.5, 100mM
NaCl, 10mM EDTA, 1% sarkosyl and 0.5% SDS. After
extraction with phenol/chloroform, the viral DNA was
precipitated with isopropanol, washed with 70% ethanol,
dissolved in TE containing 10mM Tris–HCl at pH 7.5 and
1mM EDTA.
BAC DNA from E. coli was isolated as previously
described (12). Isolation of episomal viral DNA was per-
formed according to a published method (18).
Constructionof Tn5-BAC vectors pHAIME and pHGCME
Plasmid pHAI was kindly provided by Dr Nikolaus
Osterrieder at the College of Veterinary Medicine,
Cornell University with the permission of Dr Martin
Messerle at the Institute for Virology, Hannover,
Germany. PacI-linearized pHAI consists of a mini-F
sequence, a chloramphenicol (CM) resistance gene and
the E. coli guanine phosphoribosyltransferase (gpt) selec-
tion marker, and is ﬂanked at both ends by 34-bp loxP
recombination sites (Figure 1A). An annealed double-
stranded oligonucleotide, 50-pCGAGATGTGTA
TAAGAGACAGGCGGCCGC CTGTCTCTTATACA
CATCT CGAT-30, containing AT overhangs at both
ends and one NotI site ﬂanked with two Tn5 transposase
recognition sequences as shown in underline, was then
inserted into the PacI site of pHAI to generate
pHAIME by site-speciﬁc ligation using T4 DNA ligase
(Promega, Madison, WI, USA).
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Figure 1. Schematic illustration of the strategy for eﬃcient sequence-
independent in vitro transposon-mediated cloning of genomes of large
DNA viruses as BACs. (A) NotI-linearized Tn5-based BAC vector
cassettes pHAIME and pHGCME. pHAIME contains 19bp mosaic
end Tn5 transposase recognition sequences (Tn5 ME) on both ends
of pHAI, which consists of gpt gene, CM resistance gene, mini-F
sequences and ﬂanking loxP sites. PLHAR and PLHAF were designed
for long PCR ampliﬁcation of the junction sequences. PLHAF and
PHAR were also used for DNA sequencing. pHGCME is similar to
pHAIME except the gpt cassette was replaced with a gfp cassette.
(B) Procedure for molecular cloning of the genome of a large DNA
virus as a BAC by Tn5-mediated direct in vitro transposition.
An in vitro transposon insertion reaction was carried out with viral
genomes, EZ-Tn5
TM transposase and BAC vector cassette pHAIME
or pHGCME. The reaction products were transfected into cells and
the resulting progeny viruses were used to infect new cells for isolating
viral episomal DNA. Following recovery in E. coli, BAC clones were
screened by restriction digestion and Southern blot hybridization
analysis.
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with a green ﬂuorescence protein (gfp) cassette through a
two-step recombination process as previously described
(12). The gfp cassette was ampliﬁed from plasmid
pEGFP-M with primers: 50-AGTAATCAATTACGGG
GTC ATTAGTTC-30 (FCZ17) and 50-TTTGGA TCCA
AGATACATTGATGAGTTTGGAC AA-30 (FCZ18).
The Kan cassette was generated by PCR ampliﬁcation
using EZ-Tn5
TM <KAN-2> as a template (Epicentre,
Madison, WI, USA) with primers: 50-CACGTTGTGT
CTCA AAATCTCTGATG-30 (KanF) and 50-TTTGG
ATCCGGTTGATGAGAGCTTTGTTGT AGGTG-30
(KanR). The PCR products were digested with BamHI
and ligated with T4 DNA ligase. The ligated product was
used as a template to generate a PCR product using pri-
mers: 50-CGGGCGTATTTTT TGAGTTATCGAGATT
TTCAGGAGCTAAGGAAGCTAAAATGAGCCATAT
TCAAC GGGAAAC-30 (KGF) and 50-GCCCAGCGTC
TTGTCATTGGCGAACTCGAACAC GCAGATGCA
GTCGGGGCGAGTAATCAATTACGGGGTCATTA
GTTC-30 (KGR) for the ﬁrst recombination between
pHAIME and the PCR product based on the underlined
recombination sequences to obtain pHGKME. The Kan
cassette was then replaced by a CM cassette, which was
ampliﬁed from the pHAI plasmid with primers: 50-CGG
GCGTATTTTTTGAGTTATCGAGATTTTCAGG AG
CTAAGGAAGCTAAAAT GGAGAAAAAAATCACT
GGATATACCACC-30 (CMF) and 50-GCATTTTTTTC
ACT GCATTCTAGTTGTGGTTTGTCCAAACTCAT
CAATGTATCTTACTGCCTTAAAAAAATTACGCCC
CG-30 (CMR). The product was usedfor thesecond recom-
bination with pHGKME in E. coli strain DH10B based on
the underlined recombination sequences, which resulted in
the generation of pHGCME.
Identification oftransposon integration site
PCR was performed using the indicated templates to
amplify the integration junction viral sequences with pri-
mers: 50-CGGTGTGCGGTTGTATGCCTGCTGTGG-30
(pLHAF) and 50-GATCCGCGCTTTCTCTGTCCTTC
CTGTGC-30 (pLHAR). The resulting PCR products
were sequenced using primers PLHAF and 50-CGTA
AACTCGCAAGCCG-30 (PHAR), respectively.
In vitro transpositionreaction
Two sets of experiments were performed. In the ﬁrst set, we
determined the eﬃciency of in vitro transposition of the
MHV-68 genome using the Tn5-BAC vector pHGCME,
which contains a gfp cassette to facilitate the monitoring of
cells harboring the recombinant viral genomes. Viral DNA
at 1, 0.3 and 0.1mg were used, together with molar ratios
of the Tn5-BAC vector and the MHV-68 genome main-
tained at 3:1, 1:1, 0.3:1 and 0:1, respectively. The transpo-
son reactions contained the linearized pHGCME DNA,
the MHV-68 DNA and 1 U of EZ::TN transposase
(Epicentre) in 20 ml of EZ::TN reaction buﬀer. After incu-
bation at 378C for 2h, EDTA was added to a ﬁnal concen-
tration of 10mM and the mixture was heated for 20min
at 658C to inactivate the transposase. The eﬃciencies of
transposon integration under diﬀerent conditions were
examined following transfection of the reaction products
into the NIH3T12 cells. In the second set of experiments, a
transposon reaction containing 1mg of MHV-68 DNA
together with pHAIME and viral DNA at a 1:1 molar
ratio was carried out. Individual MHV-68 BAC clones
were randomly selected for characterizations from this
set of experiments.
Transfectionof viral DNA into NIH3T3 cells and
observation ofviral plaques
Cells at 70–80% conﬂuency were transfected with in vitro
transposed viral DNA preparations using Targefect-
293F-2 Transfection reagent according to the instructions
of the manufacturer (Targeting Systems, El Cajon, CA,
USA). To visualize the eﬃciency of transposon integration
into the viral genome, the plates were scanned with a
Typhoon
TM 9410 Imaging System (GE Healthcare Bio-
Sciences Corp., Piscataway, NJ, USA) to record the num-
bers of viral plaques per plate. Individual viral plaques
were conﬁrmed with a Zeiss Axiovert 200M Fluorescent
Microscope (Carl Zeiss Microimaging Inc., Thornwood,
NY, USA).
Transfectionof episomal viral DNA into E. coli
Transfection of episomal viral DNA into E. coli was car-
ried out as previously described (12).
Restriction analysis andSouthern blot hybridization
DNA preparations of recombinant viruses were treated
with KpnI restriction enzyme, separated on 0.8% agarose
gels by electrophoresis and transferred to Zeta-Probe GT
membranes. The membrane was hybridized with a
32P-
labeled PHAI probe, and speciﬁc signals were detected
with the Typhoon
TM 9410 Imaging System.
RESULTS
Sequence-independent invitro transposon-mediated
cloningof theMHV-68 asinfectious BACs
We adapted the Tn5 transposition system from Gram-
negative bacteria (19) to insert the BAC vector into the
MHV-68 genome. We ﬁrst generated two Tn5-based BAC
vector cassettes, pHAIME and pHGCME as described in
Materials and Methods section (Figure 1A). Brieﬂy, a
50-phosphorylated oligonucleotide containing a NotI site
ﬂanked by two Tn5 mosaic sequences was inserted into the
PacI site of the pHAI plasmid, which consists of a bacter-
ial origin of replication, a CM cassette and an E. coli gpt
selection marker ﬂanked at both ends by loxP recombina-
tion sites. pHGCME was generated by replacing the gpt
cassette with a gfp cassette. We ﬁrst determined the eﬃ-
ciency of transposon integration into the viral genome by
varying the amount of viral DNA and the molar ratio
of transposon cassette versus viral DNA. In this set of
experiments, we used the pHGCME construct to facilitate
the monitoring of viral infection and replication because
of the presence of the gfp cassette. In vitro transposition
reactions containing viral DNA, EZ-Tn5
TM transposase
and the NotI-linearized pHGCME were carried out as
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NIH3T3 cells were transfected with the reaction products
to reconstitute infectious virus. We used a ﬂuorescence
imaging scanner to monitor the formation of viral plaques
at day 4 posttransfection. We observed a large number of
gfp foci in the range of 80–105 foci per plate when 1mgo f
viral DNA was used in combination with 3:1 and 1:1
molar ratios of transposon cassette versus viral DNA
(Figure 2A). These foci resembled viral plaques under a
ﬂuorescence microscope (Figure 2B), and their sizes grew
over time (data not shown), suggesting that they were
caused by infectious viruses. Indeed, we observed new
plaques following passage of the supernatants to new
plates (Figure 2C). When the molar ratio of transposon
cassette versus viral DNA was decreased to 0.3:1, the
number of plaques was reduced to 20 plaques per plate
(Figure 2A), indicating that higher molar ratios of trans-
poson cassette versus viral DNA, preferably at 1:1 or
higher, could ensure the transposon integration eﬃciency.
When the viral DNA amount was reduced to 0.3mg and
0.1mg, the number of plaques was reduced to 29 and 4 per
plate, respectively, even though the transposon and viral
DNA ratio was maintained at 3:1 (Figure 2D), indicating
that the amount of input viral DNA could signiﬁcantly
inﬂuence the number of gfp plaques. We further deter-
mined the eﬃciency of transposon integration into the
viral genome by calculating the percentage of gfp-
positive plaques in total number of plaques per plate. As
shown in Figure 2E, when the 3:1 molar ratio of transpo-
son cassette and viral DNA was used, viral DNA at both
1mg and 0.3mg gave similar transposition eﬃciencies at
7.8% and 7.2%, respectively. While reduction of the trans-
poson cassette and viral DNA ratio also led to the
decrease of transposition eﬃciencies, viral DNA at 1mg
and 0.3mg remained to have similar transposition eﬃcien-
cies (Figure 2E). When the viral DNA was decreased to
0.1mg, the eﬃciency of transposition into the MHV-68
genome was reduced to 3.0% at the 3:1 transposon cas-
sette and viral DNA molar ratio. As expected, the trans-
position eﬃciency decreased proportionally with the
reduced transposon cassette and viral DNA molar ratio.
These results suggested that higher viral DNA input, pre-
ferably at >0.3mg per reaction, combining with a higher
molar ratio of transposon cassette and viral DNA, prefer-
ably at >1:1, was required to maintain the transposition
eﬃciency. Furthermore, these results have shown that
transposon integration can be achieved with as little as
0.1mg of viral DNA.
To show the utility of this approach for cloning gen-
omes of large DNA viruses, we further characterized the
recombinant viruses cloned by in vitro transposon integra-
tion. In this set of experiments, an in vitro transposition
reaction containing 1mg of viral DNA together with a
pHAIME and viral DNA molar ratio of 1:1 was carried
out. At day 6 posttransfection, we observed complete
cytopathic eﬀect (CPE) in the culture, from which we col-
lected the supernatant containing the progeny virus, and
subsequently infected a T-25 ﬂask of NIH3T12 cells. At
day 1 postinfection, episomal viral DNA was isolated and
transformed into E. coli DH10B as described in Materials
and Methods section (Figure 1B). Following CM selec-
tion, isolated BAC colonies were grown in Luria-Bertani
medium for DNA preparation. Restriction analysis was
carried out to screen clones that contained the entire
viral genome. We obtained 150 clones containing the
pHAIME-integrated genomes, from which we randomly
selected three clones (clones 1–3) for further analysis.
To determine whether the BAC clones were infectious,
we transfected the NIH3T12 cells with the BAC DNA. We
observed extensive CPE with all three selected BAC clones
at day 5 posttransfection (data not shown). Upon passage
of the supernatants to new cultures, we also observed CPE
in the new cultures. These results indicated that all three
MHV-68 BAC clones were infectious.
Identification ofintegration sitesand adjacent
viral sequences
To determine the integration positions of the BAC cassette
in the viral genomes in each of the BAC clones, we used
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Figure 2. Eﬃciency of sequence-independent in vitro transposon-
mediated integration of genomes of large DNA viruses. (A) In vitro trans-
position was carried outwith 1mg of MHV-68 DNA under molar ratios of
pHGCME and viral genome of 3:1, 1:1, 0.3:1 and 0:1. Following trans-
fection of the reactions into NIH3T12 cells, gfp plaques were observed
with a ﬂuorescent scanner. (B) Representative individual gfp plaques
described in (A) under corresponding molar ratios of pHGCME and
viral genome observed under a ﬂuorescence microscope. One plaque
was shown for each ﬁeld. (C) Representative gfp plaques after passage
of the culture supernatants from (A) to new cultures. The plaques were
observed under a ﬂuorescence microscope. Multiple plaques were shown
in each ﬁeld. (D) The numbers of plaques per plate obtained under con-
ditions of diﬀerent viral DNA, and molar ratios of pHGCME and viral
genome. (E) Eﬃciency of transposition under conditions of diﬀerent viral
DNA, and molar ratios of pHGCME and viral genome. Transposition
eﬃciency was calculated as the percentage of gfp-positive plaques in total
number of plaques per plate.
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the cassette together with the viral sequences ﬂanking the
insertion sites (Supplementary Figure 1A). Following reli-
gation and transformation into E. coli, a new set of
pHAIME-containing plasmids was recovered. Primers
PLHAR and PLHAF located in the pHAIME cassette
(Figure 1A) were used to amplify the products from
inside the cassette extending outside to the entire circular-
ized viral sequences in the excised plasmids. We identiﬁed
independent insertion sites for the three selected BAC
clones (Supplementary Figure 1B). DNA sequencing was
carried out with primers corresponding to the pHAIME
cassette. Sequence alignments of the PCR products with
the MHV-68 genome sequence identiﬁed the insertion sites
of clones 1–3at nucleotides 4307, 9413 and 2329, respec-
tively, in relative to GenBank accession number U97553.
Genetic analysis ofthe cloned recombinant viruses
We carried out restriction analysis and Southern blot
hybridization with the three selected MHV-68 BAC
clones. As shown in Figure 3A, all three clones (1–3)
had restriction patterns similar to that of the wild-type
viral genome except in bands where the integration of
the BAC cassette occurred. The pHAIME cassette con-
tains three KpnI sites generating DNA fragments of
2551bp, 4065bp, 364bp and 307bp (Figure 3C–E).
In clone 1, the transposon cassette was inserted into a
large terminal repeat (TR)-containing band at nucleotide
4307 generating a new large TR fragment containing the
2551bp transposon cassette fragment which is indistin-
guishable from the original TR band, a new 4065bp frag-
ment, a new 364bp fragment and a new 1958bp fragment
derived from the fusion of the 307bp transposon cassette
fragment and a 1651bp right genomic fragment
(Figure 3A and C). The 364bp band was too small to be
visible on the gel. Southern hybridization detected the new
TR band, the 4065bp band and the 1958bp band
(Figure 3B). The 1958bp band was weak because of lim-
ited overlapping sequence (307bp) with the probe
(Figure 3B). In clone 2, the transposon cassette was
inserted into the 4244bp band at nucleotide 9413 generat-
ing a new 3762 fragment containing the 3455bp left geno-
mic fragment and the 307bp transposon cassette
fragment, which is indistinguishable from another 3678
genomic band, a new 364bp fragment, a new 4065bp
fragment, and a new 3340bp fragment derived from the
fusion of the 2551bp transposon cassette fragment and a
789bp right genomic fragment (Figure 3A and D). Again,
the 364bp band was too small to be visible on the gel.
Southern hybridization detected the new 3762bp band,
the 4065bp band and the 3340bp (Figure 3B). In clone
3, the transposon cassette was again inserted into the large
TR-containing band but at nt 2329 generating a new large
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Figure 3. Genetic analysis of MHV-68 BAC clones obtained by sequence-independent in vitro transposon-mediated cloning. (A) Restriction digestion
and (B) Southern blot hybridization analysis of selected BAC clones. BAC DNA from clones 1–3 as well as puriﬁed wild-type viral DNA (V) were
subjected to KpnI restriction analysis (A), and Southern blot hybridization with pHAI vector as a probe (B). (C–E) Schematic illustration of
recombinant MHV-68 clone 1 (C), clone 2 (D) and clone 3 (E), and the pHAIME cassette with positions of their KpnI sites, cassette integration sites
and corresponding DNA fragments before and after integration.
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fragment, which is indistinguishable from the original
TR band, a new 364bp fragment, a new 4065bp fragment
and a new 6180bp fragment derived from the fusion of the
2551bp transposon cassette fragment and a 3629bp right
genomic fragment (Figure 3A and E). The 364bp band
was, again, not visible on the gel. Southern hybridization
detected the new TR band, the 4065bp band and the
6180bp band (Figure 3B). Together, these genetic analyses
strongly suggested that all three clones contained the full-
length MHV-68 genome.
Since all the large DNA viruses have large genomes and
often some repeat sequences, it is essential to ensure that
the BAC clones could maintain genetic stability in E. coli.
Instability of viral genomes in E. coli has been observed
with herpesviruses (2). We serially propagated all three
clones in E. coli strain DH10B. Restriction analysis of
BAC DNA showed no detectable genomic alteration
with all three clones after eight serial passages (data not
shown), indicating the stability of the infectious BAC
clones in E. coli. Thus, under our experimental conditions,
we did not detect any instability in the recombinant BAC
clones in E. coli. Nevertheless, genetic instability might
exist for some other clones because of their special inte-
gration sites.
MHV-68 ORF-M1gene is notessential for
virus growth invitro
The identiﬁcation of integration sites of the BAC clones
should permit the selection of individual clones that could
be used for further genetic analysis of viral genes by tar-
geted mutagenesis or transposon-mediated mutagenesis in
E. coli. Furthermore, some identiﬁed clones with speciﬁc
insertion disruptions could be directly used for functional
characterizations of viral genes. As an example, we
selected clone 3 for further characterization. The integra-
tion of the BAC vector at nucleotide 2329 should disrupt
the ORF-M1 gene, which is encoded from nucleotides
2023 to 3285 of the GenBank accession number U97553.
We determined the eﬀect of ORF-M1 disruption on the
growth of MHV-68. As shown in Figure 4, the clone 3
virus grew virtually identical to the wild-type virus in
both plaque sizes on a cell monolayer and growth
curves. These results indicated that ORF-M1 was not
essential for MHV-68 replication in vitro, which was con-
sistent with results of a previous report (20).
DISCUSSION
The pioneering work of cloning the genome of murine
cytomegalovirus as an infectious BAC has revolutionized
the genetics of large DNA viruses (1). Once infectious
BACs are obtained, genetic mutations can be introduced
into the viral genomes in E. coli, and the phenotypes can
be assayed upon reconstitution of the recombinant viruses
in mammalian cells (15). The genomes of several large
DNA viruses have been cloned as BACs by homologous
recombination (1–14). These methods require multiple
laborious plaque puriﬁcations. For viruses, such as
KSHV that do not produce any plaques in culture, it is
a painstaking process that entails intensive drug-selection
and genetic screening (12). Furthermore, these methods
require some prior knowledge of the viral sequence or
cloning of a viral fragment to generate either the BAC
cassette or the BAC vector-containing cosmid insert for
homologous recombination. In this study, we have devel-
oped a novel method for cloning genomes of large DNA
viruses as BACs by combining the highly eﬃcient Tn5-
based in vitro transposition system (19) with the high capa-
city of BAC vectors (21). The process is highly eﬃcient
and requires as little as 0.1mg of viral DNA (Figure 2). As
a proof-of-concept, we have successfully cloned the MHV-
68 genome as BACs, and selected several clones with dif-
ferent integration sites. Using the same method, we have
recently cloned the rhesus rhadinovirus genome as BACs
(data not shown). As illustrated in the current study, this
method is not only eﬃcient but also simple and rapid, and
does not require prior knowledge of the viral genome
sequences.
The BAC cassette has been shown to interfere with the
growth of some viruses (22). Thus, it is desirable to excise
the BAC cassette before any functional characterizations.
The BAC cassettes used in this study, pHAIME and
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Figure 4. Growth properties of wild-type MHV-68 and BAC clone 3
virus (ORF-M1 mutant). (A) Plaque formation of wild-type MHV-68
and BAC clone 3 virus. Viral preparations of wild-type virus and
recombinant BAC clone virus from transfected cells (Figure 1B) were
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monolayers. Following 1h adsorption and removal of the viruses, the
cells were washed twice with DMEM and overlaid with 0.5%
agarose. At day 6 postinoculation, the cells were overlaid with 0.5%
agarose containing 0.03% neutral red. Following incubation for 1day,
images of the plaques were captured with a dissection microscope
with aid of a digital camera. (B) Multistep growth curves of wild-
type MHV-68 and BAC clone 3 virus on NIH3T12 cells. The
NIH3T12 cells on 6-well plates were infected with wild-type MHV-68
and BAC clone 3 virus at 0.01 multiplicity of infection, respectively.
The infected cells were collected at the indicated time points and sub-
jected to three freeze-thaw cycles. After removal of cell debris, the
supernatants were used for viral titration.
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used to excise the cassette (Figure 1A).
Although we have not attempted the experiments, the
BAC clones could potentially be recovered in E. coli
immediately following in vitro transposition. Nevertheless,
their passages in cell culture could ensure that they were
infectious (Figure 1B). Since herpesviruses often contain
defective genomes (23), defective BAC clones are com-
monly seen following BAC cloning reﬂecting the source
of the viral materials (12). While direct cloning of viral
genomes might avoid the generation of additional muta-
tions, their passage in the culture could enrich the BAC
clones that contain the full-length viral genomes and thus
facilitate the initial selection of BAC clones with growth
properties resembling the wild-type viruses, which is a pre-
requisite for their applications in genetic manipulations.
Furthermore, recirculation of the viral genomes is
required to ensure their growth in E. coli. Nevertheless,
direct recovery of the cloned genomes into E. coli should
be useful for circular viral genomes, particularly for
viruses that do not have high plaque-forming eﬃciencies.
For large DNA viruses that are close to the genome
packaging capacity, such as human cytomegalovirus,
direct recovery of the BAC clones in E. coli should oﬀer
additional advantages.
Herpesviruses can replicate as either linear or circular
genome depending on the phase of the viral lifecycle.
We have shown that the direct transposon insertion
method is highly eﬃcient in cloning linear viral genomes.
This strategy should also work for circular viral genomes.
However, the sensitivity of this method for cloning circu-
lar genomes remains to be determined.
The identiﬁcation of the BAC cassette integration site
can be achieved by direct sequencing of the BAC clone.
However, such practice remains a challenge for some
sequencing facilities because of the large sizes of the tem-
plates. We have used a simple strategy to amplify a PCR
product encompassing the integration site, which can then
be easily sequenced to determine the integration site of the
BAC cassette (Supplementary Figure 1). Such strategy has
also been used to map the transposon insertion sites of
pseudorabies virus BAC clones (8).
While hundreds of viruses have been identiﬁed and their
genomes cloned in the last century, many of them remain
to be discovered (24). The development of novel methods
has often led to the discovery of novel viruses associated
with important diseases (25–27). The fact that our method
is highly eﬃcient and does not require any prior knowl-
edge of viral sequences renders it useful for discovering
previously unidentiﬁed viruses. Once the genome of a
virus is cloned, its identity can be quickly established fol-
lowing DNA sequencing of the viral fragments adjacent to
the BAC cassette integration sites. The BAC clones can
then be immediately used for genetic and molecular char-
acterizations of the newly identiﬁed viruses.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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